Skip to main content

Sepsis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis

    open to eligible people ages 18 years and up

    Multicenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension.

    San Francisco, California and other locations